NephrologyOnline.net

Nephrology Xagena

Search results for "CKD"

The FDA ( Food and Drug Administration ) has approved Zemplar ( Paricalcitol ) capsules, an oral, activated vitamin D therapy for prevention and treatment of secondary hyperparathyroidism ( SHPT ). ...


A Mayo Clinic study found men who experience signs and symptoms of a prostate obstruction resulting from benign prostatic hyperplasia ( BPH ) are three times more likely than other men to develop chr ...


Results from the FIND-CKD study were presented at the American Society of Nephrology ( ASN ) Kidney Week in Atlanta, Georgia, USA. The FIND-CKD results have shown that Ferinject ( Ferric carboxymaltos ...


Tolvaptan ( Samsca ), a diuretic with a new mechanism of action, selectively binds to the vasopressin V2 receptor and inhibits reabsorption of water. Its effect on heart failure is proven, but its ben ...


Tolvaptan ( Samsca ), a diuretic with a new mechanism of action, selectively binds to the vasopressin V2 receptor and inhibits reabsorption of water. Its effect on heart failure is proven, but its ben ...


The two largest studies of mammalian target of rapamycin inhibitor treatment of autosomal dominant polycystic kidney disease ( ADPKD ) have demonstrated no clear benefit on the primary endpoint of tot ...


Abnormal mineral metabolism is a hallmark in patients with advanced chronic kidney disease ( CKD ). Hyperphosphatemia, and the homeostatic mechanisms controlling phosphate metabolism, have received pa ...


The concept of chronic kidney disease - mineral bone disorder ( CKD-MBD ) does not appear to fulfil the requirements for a syndrome at first glance, but its definition has brought some clear-cut benef ...


In phase 4 IMPACT-SHPT study, efficacy and safety of Paricalcitol-centred therapy were compared with that of Cinacalcet-centred therapy for the treatment of chronic kidney disease (CKD)-associated sec ...


Endothelial dysfunction underlies multiple cardiovascular consequences of chronic kidney disease ( CKD ) and antecedent diabetes or hypertension. Endothelial insults in chronic kidney disease or end-s ...


A study has assessed the effect of Pentoxifylline [ Trental ] on proteinuria and renal function in chronic kidney disease ( CKD ) treatment. Researchers systematically searched randomized and non- ...


Periodontitis may add to the systemic inflammatory burden in individuals with chronic kidney disease ( CKD ), thereby contributing to an increased morality rate. A study aimed to determine the assoc ...


While Darbepoetin alfa ( Aranesp ) can be administered once monthly ( QM ) to maintain haemoglobin ( Hb ) concentrations in anaemic patients with chronic kidney disease not on dialysis ( CKD-ND ), the ...


Safety concerns with erythropoietin analogues and intravenous ( IV ) iron for treatment of anemia in chronic kidney disease ( CKD ) necessitate development of safer therapies. Roxadustat ( FG-4592 ...


Limited prospective data are available on the long-term safety of Darbepoetin alfa ( Aranesp ) for treating anemia in children with chronic kidney disease ( CKD ). In this prospective, phase IV, ob ...